Lilly Endowment Inc - Aug 31, 2023 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
10%+ Owner
Signature
/s/ Diane M. Stenson, Vice President & Treasurer, on behalf of Lilly Endowment Inc.
Stock symbol
LLY
Transactions as of
Aug 31, 2023
Transactions value $
-$25,821,607
Form type
4
Date filed
9/1/2023, 04:00 PM
Previous filing
Aug 31, 2023
Next filing
Sep 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Sale -$18.2M -32.9K -0.03% $554.38 100M Aug 31, 2023 Direct F1
transaction LLY Common Stock Sale -$4.61M -8.31K -0.01% $555.35 100M Aug 31, 2023 Direct F2
transaction LLY Common Stock Sale -$2.47M -4.44K 0% $556.58 100M Aug 31, 2023 Direct F3
transaction LLY Common Stock Sale -$501K -900 0% $557.19 100M Aug 31, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $554.00 to $554.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $555.00 to $555.97, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $556.03 to $557.02, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $557.03 to $557.37, inclusive.